Xiao Yao San (Rambling Powder, Free and Easy Wanderer)

Actions

Indications

Western Uses:

• What is Xiao Yao San used for in modern/integrative practice?

  In Japanese Kampo medicine the plain formula is known as Shoyosan and is referenced for premenstrual and menopausal irritability, fatigue, and mild mood symptoms fitting a blood-deficiency-with-stagnation pattern — distinct from the more heavily studied augmented Kampo formula Kamishoyosan (Tsumura TJ-24, corresponding to Jia Wei/Dan Zhi Xiao Yao San), which carries most of the Japanese clinical-trial literature (see research). In US/European TCM and integrative practice, Xiao Yao San (commonly sold as the pill Xiao Yao Wan) is referenced for PMS, perimenopausal mood symptoms, and stress-related digestive complaints that fit a Liver-Spleen disharmony pattern.

  Source: Kampo formulary references (Shoyosan vs Kamishoyosan naming) + clinical literature cited in research; reference only, not a treatment claim.

Originally Appeared In:

• Imperial Grace Formulary of the Tai Ping Era (Tai Ping Hui Min He Ji Ju Fang)

Notes:

• How does Xiao Yao San differ from Jia Wei Xiao Yao San and Chai Hu Shu Gan San?

  Xiao Yao San, Jia Wei Xiao Yao San, and Chai Hu Shu Gan San all course the Liver, but they are built for three different depths of the same problem — plain stagnation with deficiency, stagnation that has generated heat, and pure stagnation without deficiency.

  • Jia Wei Xiao Yao San (Dan Zhi Xiao Yao San, “Augmented Rambling Powder”): the Ming-dynasty physician Xue Ji (1487–1559) added Mu Dan Pi and Zhi Zi to this base formula in his Nei Ke Zhai Yao (“Essentials of Internal Medicine,” c. 1529) to clear the heat that develops when Liver constraint runs long enough to transform into fire — irritability, a red tongue (especially the tip and sides), a more rapid or wiry-rapid pulse, and sometimes breast tenderness with a burning quality. Xiao Yao San itself carries no heat-clearing herb and is not built for that presentation.
  • Chai Hu Shu Gan San (“Bupleurum Powder to Spread the Liver”): from Zhang Jiebin’s (Zhang Jingyue) Jing Yue Quan Shu (“Jingyue’s Complete Works,” Ming dynasty, c. 1624), this formula pairs Chai Hu with Chen Pi, Chuan Xiong, Xiang Fu, Zhi Ke, Bai Shao, and Gan Cao — a stronger qi-moving, pain-relieving combination built for pronounced distending or stabbing rib-side/chest pain from pure Liver qi stagnation. It has no dedicated blood-nourishing pair (Dang Gui is absent) and no Spleen-fortifying Bai Zhu/Fu Ling, so it suits a more excess presentation without the blood deficiency and Spleen weakness that Xiao Yao San is built to address.

  Source: Bensky & Barolet, Formulas & Strategies (formula comparisons, historical sources) + Chen & Chen, Chinese Medical Herbology and Pharmacology (Jia Wei Xiao Yao San and Chai Hu Shu Gan San composition).

Clinical Studies & Research:

• Is there modern research on Xiao Yao San?

  Yes — the largest body of clinical evidence covers depression, anxiety, and functional gastrointestinal disorders, generally as an adjunct to conventional treatment rather than a proven stand-alone therapy, with reviewers consistently flagging low-to-moderate trial quality.

  • Depression (systematic review, 26 RCTs, 1,837 patients): a systematic review of trials using both plain Xiao Yao San and several modified versions found the combination of Xiao Yao San with antidepressants outperformed antidepressants alone on the Hamilton Depression Rating Scale and other outcome measures; standard Xiao Yao San alone showed mixed results against placebo, and overall trial quality was rated generally low (PMID 21869903).
  • Anxiety (meta-analysis, 9 RCTs, 809 patients): Xiao Yao San, alone or combined with conventional anxiolytics, produced greater improvement in anxiety symptoms and fewer adverse reactions than anxiolytics alone (PMID 35432568).
  • Functional gastrointestinal disorders (meta-analysis, 48 RCTs, 4,403 patients): Xiao Yao San, alone or combined with conventional medication, improved symptom resolution and reduced recurrence across functional dyspepsia, irritable bowel syndrome, and functional constipation, with few adverse effects reported (PMID 35126152).
  • Mechanism (network pharmacology, 2020): laboratory analysis identified paeoniflorin (from Bai Shao) among the formula’s active constituents acting on hub genes including AKT1, TP53, and VEGFA, suggesting a multi-pathway effect touching metabolic, neuroendocrine, and neuroimmune signaling relevant to depression models (PMID 32256358).

  Related but distinct: the augmented variant (Jia Wei/Dan Zhi Xiao Yao San, studied in the Kampo literature as “Free and Easy Wanderer Plus”) has its own separate trial base — for example, a 2011 meta-analysis of 14 RCTs found it more effective than placebo and, combined with antidepressants, more effective than antidepressants alone (PMID 21820672) — and should not be read as evidence for the plain formula covered on this page.

  Sources: PubMed 21869903; PubMed 35432568; PubMed 35126152; PubMed 32256358; PubMed 21820672 (augmented-variant research, cited for comparison only). Research context, not a therapeutic claim; trial quality is generally low-to-moderate across this literature.